BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33749070)

  • 1. Dysregulation of LINC00470 and METTL3 promotes chemoresistance and suppresses autophagy of chronic myelocytic leukaemia cells.
    Lai X; Wei J; Gu XZ; Yao XM; Zhang DS; Li F; Sun YY
    J Cell Mol Med; 2021 May; 25(9):4248-4259. PubMed ID: 33749070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA LINC00470 promotes the degradation of PTEN mRNA to facilitate malignant behavior in gastric cancer cells.
    Yan J; Huang X; Zhang X; Chen Z; Ye C; Xiang W; Huang Z
    Biochem Biophys Res Commun; 2020 Jan; 521(4):887-893. PubMed ID: 31711642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC00470 represses cell autophagy and cisplatin sensitivity of glioma via suppressing PTEN expression.
    Chen B; Wang W; Lin F; Shi S; Ou S; Yu Y
    Folia Neuropathol; 2023; 61(1):88-96. PubMed ID: 37114964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML.
    Zhao L; Shan Y; Liu B; Li Y; Jia L
    Cell Death Dis; 2017 May; 8(5):e2830. PubMed ID: 28542127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
    Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
    Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depleting long noncoding RNA HOTAIR attenuates chronic myelocytic leukemia progression by binding to DNA methyltransferase 1 and inhibiting PTEN gene promoter methylation.
    Song H; Chen L; Liu W; Xu X; Zhou Y; Zhu J; Chen X; Li Z; Zhou H
    Cell Death Dis; 2021 May; 12(5):440. PubMed ID: 33941772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
    FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of m
    Liu S; Li Q; Li G; Zhang Q; Zhuo L; Han X; Zhang M; Chen X; Pan T; Yan L; Jin T; Wang J; Lv Q; Sui X; Xie T
    Cell Death Dis; 2020 Nov; 11(11):969. PubMed ID: 33177491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN Is Fundamental for Elimination of Leukemia Stem Cells Mediated by GSK126 Targeting EZH2 in Chronic Myelogenous Leukemia.
    Zhou J; Nie D; Li J; Du X; Lu Y; Li Y; Liu C; Dai W; Wang Y; Jin Y; Pan J
    Clin Cancer Res; 2018 Jan; 24(1):145-157. PubMed ID: 29070525
    [No Abstract]   [Full Text] [Related]  

  • 14. METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.
    Li H; Wang C; Lan L; Yan L; Li W; Evans I; Ruiz EJ; Su Q; Zhao G; Wu W; Zhang H; Zhou Z; Hu Z; Chen W; Oliveira JM; Behrens A; Reis RL; Zhang C
    Cell Mol Life Sci; 2022 Feb; 79(3):135. PubMed ID: 35179655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide protects against the progression of glioblastoma via SOX4 downregulation by inhibiting the LINC00470-mediated transcription factor EGR2.
    Li W; Wang M; Ma W; Liu P; Zhang M; He J; Cui Y
    CNS Neurosci Ther; 2023 Aug; 29(8):2292-2307. PubMed ID: 36987665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
    Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct EphB4-mediated mechanisms of apoptotic and resistance to dasatinib in human chronic myeloid leukemia and K562 cell lines.
    Zhao WH; Huang BT; Zhang JY; Zeng QC
    Leuk Res; 2017 Dec; 63():28-33. PubMed ID: 29096333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morin Inhibits Proliferation and Induces Apoptosis by Modulating the miR-188-5p/PTEN/AKT Regulatory Pathway in CML Cells.
    Nie ZY; Yang L; Liu XJ; Yang Z; Yang GS; Zhou J; Qin Y; Yu J; Jiang LL; Wen JK; Luo JM
    Mol Cancer Ther; 2019 Dec; 18(12):2296-2307. PubMed ID: 31515296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
    Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
    Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.